Biotech Growth (UK) Insiders

Biotech Growth Management Team Effectiveness

The company has return on total asset (ROA) of 0.1698 % which means that it generated a profit of $0.1698 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2979 %, meaning that it generated $0.2979 on every $100 dollars invested by stockholders. Biotech Growth's management efficiency ratios could be used to measure how well Biotech Growth manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Biotech Growth's Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 333.7 M in 2025, whereas Other Current Assets are likely to drop slightly above 16.1 K in 2025. Common Stock Shares Outstanding is likely to gain to about 40.5 M in 2025, despite the fact that Net Loss is likely to grow to (35.3 M).

Biotech Growth Workforce Comparison

The company has Profit Margin (PM) of 0.95 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.8 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.8.

Biotech Growth Benchmark Summation

Biotech Growth Stakeholder

The success or failure of an entity such as Biotech Growth often depends on how effective the management is. Biotech Growth management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Biotech management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Biotech management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Biotech Growth's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of The Biotech Growth. Check Biotech Growth's Beneish M Score to see the likelihood of Biotech Growth's management manipulating its earnings.

When running Biotech Growth's price analysis, check to measure Biotech Growth's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotech Growth is operating at the current time. Most of Biotech Growth's value examination focuses on studying past and present price action to predict the probability of Biotech Growth's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotech Growth's price. Additionally, you may evaluate how the addition of Biotech Growth to your portfolios can decrease your overall portfolio volatility.